Funded with Support from

A 6-month-old girl with no symptoms is brought to her pediatrician’s office by her mother, who has noticed a white shadow in the child’s right eye.

This retrospective study reports the outcomes of canalicular laceration repair with the Mini Monoka stent (FCI Ophthalmics) in children younger than 10 years.

In this 1-Minute Video, Dr. H. Joon Kim offers pearls for managing congenital nasolacrimal duct obstruction (NLDO).

In this presentation from the Pediatric Ophthalmology Subspecialty Day 2019, Dr. Edward Wladis discusses the benefits of balloon dacryoplasty after a failed initial probing, highlighting eight articles and their findings.

Drs. Epley and Orge moderate this virtual journal club with Drs. Pennesi, Ghadban, and Abramson. Articles included: Treatment of Retinoblastoma in 2015: Agreement and Disagreement (David H. Abramson, MD, FACS); The incidence and clinical characteristics of adult-onset convergence insufficiency (Rafif Ghadban, MD); and Results at 2 Years after Gene Therapy for RPE65-Deficient Leber Congenital Amaurosis and Severe Early-Childhood-Onset Retinal Dystrophy (Mark Pennesi, MD)

In this study, investigators described changes in refraction and amblyopia in children undergoing surgery for congenital ptosis.

This report by a multidisciplinary task force is the first consensus statement on clinical care guidelines for pediatric orbital-periorbital plexiform neurofibromas (OPPNs).

Nasolacrimal duct obstruction is usually caused by persistence of a membrane at the distal valve of Hasner. The primary symptoms are epiphora and periocular crusting and discharge due to infection of the lacrimal system. Various surgical and nonsurgical treatment options for children are discussed.

Weekly case challenge